Luethy Rebecca E, Lipinski Renee C, West Jennifer L
Centurion, Sterling, VA.
Diabetes Spectr. 2023 Dec 5;37(3):247-253. doi: 10.2337/ds23-0036. eCollection 2024 Summer.
Using continuous glucose monitoring (CGM) improves diabetes-related outcomes in the community, yet the fingerstick blood glucose monitoring (BGM) method is the norm in prisons. The purpose of this study was to investigate the safety and patient perceptions of CGM in the carceral environment, quantify changes in A1C after initiating CGM, and investigate rates of emergency department (ED) visits for diabetes-related complications comparing CGM users to patients using BGM.
This pragmatic longitudinal analysis was conducted in two parts. A pilot program was carried out at a single women's prison. A CGM program was initiated at men's facilities within a single U.S. state, where A1C change and ED visit rates were investigated.
Interested patients at an appropriate security level were invited to use CGM. Pre- and post-CGM surveys of glucose monitoring perceptions were administered during the pilot program. Security and perceptions were analyzed descriptively. A1C change was assessed using a test. Fisher exact test, Barnard exact test, and post hoc power analysis were applied to ED visits.
Security was not disrupted. Patient perceptions of glucose monitoring improved with CGM use ( = 6). A1C declined by 0.60% with a medium effect size (Cohen -0.45, = 42). Power to detect a difference in ED visits was low; however, no CGM patients had an ED visit ( = 758).
It is safe and efficacious to replace BGM with CGM in prisons when patients are engaged in their care and are at a security level allowing CGM devices in their cells.
在社区中,使用连续血糖监测(CGM)可改善糖尿病相关结局,但监狱中常规采用的是指尖血糖监测(BGM)方法。本研究的目的是调查在监狱环境中使用CGM的安全性和患者感受,量化启动CGM后糖化血红蛋白(A1C)的变化,并比较CGM使用者与使用BGM的患者因糖尿病相关并发症前往急诊科(ED)就诊的比率。
这项实用的纵向分析分为两个部分。在一所女子监狱开展了一个试点项目。在美国一个州内的男子监狱启动了一项CGM项目,对A1C变化和ED就诊率进行调查。
邀请安全级别合适且感兴趣的患者使用CGM。在试点项目期间,对血糖监测感受进行了CGM使用前后的调查。对安全性和感受进行描述性分析。使用t检验评估A1C变化。对ED就诊情况应用Fisher精确检验、Barnard精确检验和事后功效分析。
安全性未受干扰。随着CGM的使用,患者对血糖监测的感受有所改善(P = 6)。A1C下降了0.60%,效应量中等(Cohen's d = -0.45,n = 42)。检测ED就诊差异的功效较低;然而,没有CGM患者前往ED就诊(n = 758)。
当患者参与自身护理且安全级别允许在其牢房中使用CGM设备时,在监狱中用CGM取代BGM是安全有效的。